Abstract
Whether the sympathetic counter‐regulatory response to hypoglycaemia is activated by glucose sensing neurons in the fore‐or hind‐brain remains controversial, since systemic hypoglycaemia excites neurons located in both areas. Here, we hypothesize that neurons in the perifornical hypothalamus (PeH), but not in the rostral ventrolateral medulla (RVLM), sense the reduction in glycaemia and increase the adrenal sympathetic nerve activity (ASNA). Experiments were conducted in anaesthetized (urethane, 1.2 g/kg i.v.), paralysed (pancuronium bromide, 1 mg/kg i.v.), and artificially ventilated male Sprague‐Dawley rats. Local glucopaenia, induced by bilateral microinjections of 2‐deoxy‐D‐glucose (2DG; 15 ng/50 nl) into the PeH, increased ASNA (101±1% vs 175±11%, N=10; P<0.05) and blood glucose (6.6±0.3 vs 7.6±0.3 mmol/l, N=9; P<0.05). A higher dose of 2DG (150 ng/50 nl) further increased ASNA (157±7% vs 280±59%, N=6; P<0.05) and blood glucose (7.5±0.5 vs.9.6±0.5 mmol/l, N=4; P<0.05). Microinjections of 2DG (15 ng/50 nl) into the RVLM (N=6) neither changed ASNA (101±1% vs 84±14%) nor blood glucose (6.4±0.1 vs 6.9±0.1 mmol/l). Subsequent intravenous infusion of 2DG (250 mg/kg) increased ASNA (101±1% vs 183±8%; P<0.05). The results indicate that neurons in the PeH, but not in the RVLM, are glucose sensitive and their excitation produces adrenaline release in response to glucoprivation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.